9 Best Life Insurance Stocks to Buy Now

5. MetLife, Inc. (NYSE:MET)

Number of Hedge Fund Holders: 39

Analysts’ Upside Potential as of December 4: 19.18%

MetLife, Inc. (NYSE: MET)  is among the Best Insurance Stocks. 

As of December 5, analyst opinions on MetLife, Inc. (NYSE: MET) are modestly positive, with more than 60% of analysts assigning it a Buy or equivalent rating. The consensus 1-year median price target is $93, implying over 18%-19% upside.

MetLife, Inc. (NYSE: MET) announced Q4 2025 preferred stock dividends across three series, according to Business Wire on November 17, 2025. The business announced a quarterly dividend of $0.33 per share on its Series A preferred stock (MET PRA), which is non-cumulative and has a $25 liquidation preference.

Moreover, MetLife, Inc. (NYSE: MET) disclosed $296.875 per share on its 4.75% Series F preferred stock (MET PRF), which is equivalent to $0.296875 per depositary share, and $351.5625 per share on its 5.625% Series E preferred stock (MET PRE), which is equivalent to $0.3515625 per depositary share. All dividends will be paid on December 15, 2025, to shareholders of record as of Friday, November 28, 2025, due to the record date falling on Sunday, November 30, 2025.

On December 1, 2025, Business Wire reported that MetLife, Inc. (NYSE:MET) had completed the transfer of $10 billion in variable annuity risk to Talcott Resolution Life Insurance Company. The transaction will result in foregone annual adjusted earnings of ~$100 million, offset by ~$45 million in annual hedge cost savings. The transaction expedites the run-off of conventional U.S. Retail segment businesses and lowers risk exposure within MetLife Holdings. MetLife Investment Management has signed new agreements with Talcott to manage around $6 billion in assets.

MetLife, Inc. (NYSE:MET) is one of the major life insurers in the United States by assets, providing an extensive portfolio of life insurance and annuity products.